AKUMS — Akums Drugs and Pharmaceuticals Share Price
0.000.00%
Last trade - 00:00- IN₹81.24bn
- IN₹78.43bn
- IN₹41.78bn
- 59
- 18
- 42
- 32
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 23.02 | ||
| PEG Ratio (f) | 0.99 | ||
| EPS Growth (f) | 30.23% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.87 | ||
| Price to Tang. Book | 2.88 | ||
| Price to Free Cashflow | 44.62 | ||
| Price to Sales | 1.94 | ||
| EV to EBITDA | 17.2 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 10.88% | ||
| Return on Equity | -0.24% | ||
| Operating Margin | 7.91% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | n/a | 27,226.29 | 36,718.93 | 36,548.2 | 41,781.82 | 40,897 | 45,732.5 | 15.35% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | -90.64 | +2042.42 | +30.23 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Akums Drugs and Pharmaceuticals Limited is an India-based pharmaceutical contract development and manufacturing company. The Company offers a comprehensive range of pharmaceutical products and services in India and overseas. It is also engaged in the sale of branded pharmaceutical formulations and manufacturing of active pharmaceutical ingredients. The Company’s segments include Contract Development and Manufacturing Operations (CDMO), Active Pharmaceutical Ingredient (API) and Branded and Generic formulations. The CDMO segment is engaged in the formulation research and development, preparation and regulatory filing of dossiers, manufacturing formulations on a contract basis, job work and testing services. The API segment is engaged in the manufacture and sale of key starting materials, Intermediate and API products. The Branded and Generic formulations segment is engaged in marketing and distribution of branded and generic pharmaceutical formulations.
Directors
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- April 19th, 2004
- Public Since
- August 6th, 2024
- No. of Employees
- 7,388
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 153,105,000
- Address
- Mangolpuri Ind. Area, DELHI, 110083
- Web
- https://www.akums.in/
- Phone
- +91 1169041000
- Auditors
- Walker Chandiok & Co LLP
Upcoming Events for AKUMS
Similar to AKUMS
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
What is the Akums Drugs and Pharmaceuticals share price?
As of Today at 19:09 UTC, shares in Akums Drugs and Pharmaceuticals are trading at IN₹530.60. This share price information is delayed by 15 minutes.
How has the Akums Drugs and Pharmaceuticals share price performed this year?
Shares in Akums Drugs and Pharmaceuticals last closed at IN₹530.60 and the price had moved by over the past 365 days. In terms of relative price strength the Akums Drugs and Pharmaceuticals share price has matched the S&P BSE 100 Index by over the past year.
What are the analyst and broker recommendations for Akums Drugs and Pharmaceuticals?
The overall consensus recommendation for Akums Drugs and Pharmaceuticals is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Akums Drugs and Pharmaceuticals dividend yield?
Akums Drugs and Pharmaceuticals does not currently pay a dividend.
Does Akums Drugs and Pharmaceuticals pay a dividend?
Akums Drugs and Pharmaceuticals does not currently pay a dividend.
When does Akums Drugs and Pharmaceuticals next pay dividends?
Akums Drugs and Pharmaceuticals does not currently pay a dividend.
How do I buy Akums Drugs and Pharmaceuticals shares?
To buy shares in Akums Drugs and Pharmaceuticals you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Akums Drugs and Pharmaceuticals?
As of the previous close price of IN₹530.60, shares in Akums Drugs and Pharmaceuticals had a market capitalisation of IN₹81.24bn.
Where are Akums Drugs and Pharmaceuticals shares listed?
Here are the trading details for Akums Drugs and Pharmaceuticals:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: AKUMS
What kind of share is Akums Drugs and Pharmaceuticals?
Based on an overall assessment of its quality, value and momentum Akums Drugs and Pharmaceuticals is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Akums Drugs and Pharmaceuticals share price forecast for 2025?
The analyst consensus target price for shares in Akums Drugs and Pharmaceuticals is IN₹775.00. That is 46.06% above the last closing price of IN₹530.60.
Analysts covering Akums Drugs and Pharmaceuticals currently have a consensus Earnings Per Share (EPS) forecast of IN₹17.70 for the next financial year.
Find out moreWhat is the trend in the Akums Drugs and Pharmaceuticals share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Akums Drugs and Pharmaceuticals. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -36.12%.
As of the last closing price of IN₹530.60, shares in Akums Drugs and Pharmaceuticals were trading -21.58% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Akums Drugs and Pharmaceuticals PE Ratio?
The Akums Drugs and Pharmaceuticals PE ratio based on its reported earnings over the past 12 months is 23.02. The shares last closed at IN₹530.60.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Akums Drugs and Pharmaceuticals?
We do not have data on Akums Drugs and Pharmaceuticals' directors